ImmunoPrecise Antibodies Ltd. filed a report on June 25, 2024, confirming they will file annual reports under Form 20-F. This filing is neutral and not considered significant for investors.
AI Assistant
IMMUNOPRECISE ANTIBODIES LTD
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.